生物
脂肪组织
特雷姆2
免疫系统
白色脂肪组织
细胞生物学
葡萄糖稳态
脂肪细胞
巨噬细胞
平衡
免疫学
内分泌学
遗传学
肥胖
胰岛素抵抗
髓系细胞
体外
作者
Diego Adhemar Jaitin,Lorenz Adlung,Christoph A. Thaiss,Assaf Weiner,Baoguo Li,Hélène C. Descamps,Patrick Lundgren,Camille Blériot,Zhaoyuan Liu,Aleksandra Deczkowska,Hadas Keren‐Shaul,Eyal David,Niv Zmora,Shai Meron Eldar,Nir Lubezky,Oren Shibolet,David A. Hill,Mitchell A. Lazar,Marco Colonna,Florent Ginhoux,Hagit Shapiro,Eran Elinav,Ido Amit
出处
期刊:Cell
[Elsevier]
日期:2019-06-27
卷期号:178 (3): 686-698.e14
被引量:864
标识
DOI:10.1016/j.cell.2019.05.054
摘要
Immune cells residing in white adipose tissue have been highlighted as important factors contributing to the pathogenesis of metabolic diseases, but the molecular regulators that drive adipose tissue immune cell remodeling during obesity remain largely unknown. Using index and transcriptional single-cell sorting, we comprehensively map all adipose tissue immune populations in both mice and humans during obesity. We describe a novel and conserved Trem2+ lipid-associated macrophage (LAM) subset and identify markers, spatial localization, origin, and functional pathways associated with these cells. Genetic ablation of Trem2 in mice globally inhibits the downstream molecular LAM program, leading to adipocyte hypertrophy as well as systemic hypercholesterolemia, body fat accumulation, and glucose intolerance. These findings identify Trem2 signaling as a major pathway by which macrophages respond to loss of tissue-level lipid homeostasis, highlighting Trem2 as a key sensor of metabolic pathologies across multiple tissues and a potential therapeutic target in metabolic diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI